-+ 0.00%
-+ 0.00%
-+ 0.00%

Why SELLAS Life Sciences Group shares are falling today

Barchart·11/19/2026 12:26:28
Listen to the news

SLS Cover Image

What happened?

Shares of SELLAS Life Sciences Group fell 19.1% in the afternoon session after the company priced an underwritten public offering of 11,538,462 shares of its common stock at $13.00 per share. 

According to a press release, all of the shares in the offering will be sold by the company, with gross proceeds expected to be $150.0 million before deducting underwriting discounts, commissions and offering expenses. The release also stated that the company granted the underwriters a 30-day option to purchase up to 1,730,769 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. 

The offering is expected to close on November 20, 2026, subject to the satisfaction of customary closing conditions.

The shares were trading at $14.80, down 17.7% from the previous close.

What is the market telling us

The previous big move we wrote about was 2 days ago when the stock gained 161% on the news that positive topline results from its Phase 3 REGAL trial showed its immunotherapeutic cancer vaccine galinpepimut-S (GPS) improved overall survival in patients with acute myeloid leukemia. 

According to a Form 8-K filing with the U.S. Securities and Exchange Commission, the company announced the data on November 17, 2026, reporting that the randomized trial met its primary endpoint of overall survival. The filing showed that GPS demonstrated a statistically significant 41% reduction in the risk of death compared with investigator's choice of best available treatment, with a hazard ratio of 0.59 and a two-sided p=0.035. The filing also showed a median overall survival of 24.0 months among GPS-treated patients versus 14.7 months with best available treatment. 

According to an exhibit to the filing, the company plans to meet with the U.S. Food and Drug Administration (FDA) while advancing preparations for a Biologics License Application (BLA) submission for GPS.

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.